Fmcna - Faulkner County is a medicare approved dialysis facility center in Conway, Arkansas and it has 10 dialysis stations. It is located in Faulkner county at 201 Skyline Dr Ste 32, Conway, AR, 72032. You can reach out to the office of Fmcna - Faulkner County at (501) 329-7715. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fmcna - Faulkner County has the following ownership type - Profit. It was first certified by medicare in December, 1988. The medicare id for this facility is 042518 and it accepts patients under medicare ESRD program.
| Name | Fmcna - Faulkner County |
|---|---|
| Location | 201 Skyline Dr Ste 32, Conway, Arkansas |
| No. of Dialysis Stations | 10 |
| Medicare ID | 042518 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 201 Skyline Dr Ste 32, Conway, Arkansas, 72032 | |
| (501) 329-7715 | |
News Archive
The National Institutes of Health has awarded a three-year, $437,248 grant to a University of Arkansas biomedical engineering researcher to design and test a biomaterial that can regenerate damaged skeletal muscle.
Allegheny Technologies Incorporated today provided guidance for the third quarter 2010. ATI expects net income per share for the third quarter 2010 before certain charges to be approximately $0.26.
A mouse model of endometriosis has been developed that produces endometriosis lesions similar to those found in humans, according to a report published in The American Journal of Pathology.
Duke University researchers have identified a receptor on the surface of cells that may give them another avenue of attack against glioblastoma, the most common and most deadly type of brain cancer.
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease - pridopidine or dopamine stabiliser ACR16 - might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival.
› Verified 2 days ago
| NPI Number | 1912019811 |
| Organization Name | Conway Dialysis |
| Doing Business As | Little Rock Dialysis Inc |
| Address | 201 Skyline Dr Conway, Arkansas, 72032 |
| Phone Number | (501) 329-7715 |
News Archive
The National Institutes of Health has awarded a three-year, $437,248 grant to a University of Arkansas biomedical engineering researcher to design and test a biomaterial that can regenerate damaged skeletal muscle.
Allegheny Technologies Incorporated today provided guidance for the third quarter 2010. ATI expects net income per share for the third quarter 2010 before certain charges to be approximately $0.26.
A mouse model of endometriosis has been developed that produces endometriosis lesions similar to those found in humans, according to a report published in The American Journal of Pathology.
Duke University researchers have identified a receptor on the surface of cells that may give them another avenue of attack against glioblastoma, the most common and most deadly type of brain cancer.
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease - pridopidine or dopamine stabiliser ACR16 - might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival.
› Verified 2 days ago
| Dialysis patients with Hemoglobin data | 12 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 42 |
News Archive
The National Institutes of Health has awarded a three-year, $437,248 grant to a University of Arkansas biomedical engineering researcher to design and test a biomaterial that can regenerate damaged skeletal muscle.
Allegheny Technologies Incorporated today provided guidance for the third quarter 2010. ATI expects net income per share for the third quarter 2010 before certain charges to be approximately $0.26.
A mouse model of endometriosis has been developed that produces endometriosis lesions similar to those found in humans, according to a report published in The American Journal of Pathology.
Duke University researchers have identified a receptor on the surface of cells that may give them another avenue of attack against glioblastoma, the most common and most deadly type of brain cancer.
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease - pridopidine or dopamine stabiliser ACR16 - might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival.
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 25 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 216 |
| Percentage of adult patients getting regular hemodialysis at the center | 94 |
News Archive
The National Institutes of Health has awarded a three-year, $437,248 grant to a University of Arkansas biomedical engineering researcher to design and test a biomaterial that can regenerate damaged skeletal muscle.
Allegheny Technologies Incorporated today provided guidance for the third quarter 2010. ATI expects net income per share for the third quarter 2010 before certain charges to be approximately $0.26.
A mouse model of endometriosis has been developed that produces endometriosis lesions similar to those found in humans, according to a report published in The American Journal of Pathology.
Duke University researchers have identified a receptor on the surface of cells that may give them another avenue of attack against glioblastoma, the most common and most deadly type of brain cancer.
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease - pridopidine or dopamine stabiliser ACR16 - might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival.
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fmcna - Faulkner County with elevated calcium levels.
| Patients with hypercalcemia | 26 |
| Hypercalcemia patient months | 221 |
| Patients with Serumphosphor | 28 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 28 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 24 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 22 |
| Patients with Serumphosphor greater than 7 mg/dL | 16 |
News Archive
The National Institutes of Health has awarded a three-year, $437,248 grant to a University of Arkansas biomedical engineering researcher to design and test a biomaterial that can regenerate damaged skeletal muscle.
Allegheny Technologies Incorporated today provided guidance for the third quarter 2010. ATI expects net income per share for the third quarter 2010 before certain charges to be approximately $0.26.
A mouse model of endometriosis has been developed that produces endometriosis lesions similar to those found in humans, according to a report published in The American Journal of Pathology.
Duke University researchers have identified a receptor on the surface of cells that may give them another avenue of attack against glioblastoma, the most common and most deadly type of brain cancer.
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease - pridopidine or dopamine stabiliser ACR16 - might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival.
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 34 |
| Patient months included in arterial venous fistula and catheter summaries | 175 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 51 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 14 |
News Archive
The National Institutes of Health has awarded a three-year, $437,248 grant to a University of Arkansas biomedical engineering researcher to design and test a biomaterial that can regenerate damaged skeletal muscle.
Allegheny Technologies Incorporated today provided guidance for the third quarter 2010. ATI expects net income per share for the third quarter 2010 before certain charges to be approximately $0.26.
A mouse model of endometriosis has been developed that produces endometriosis lesions similar to those found in humans, according to a report published in The American Journal of Pathology.
Duke University researchers have identified a receptor on the surface of cells that may give them another avenue of attack against glioblastoma, the most common and most deadly type of brain cancer.
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease - pridopidine or dopamine stabiliser ACR16 - might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival.
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 24 |
| Hospitalization Rate in facility | 199.1 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 428.1 |
| Hospitalization Rate: Lower Confidence Limit | 98.4 |
News Archive
The National Institutes of Health has awarded a three-year, $437,248 grant to a University of Arkansas biomedical engineering researcher to design and test a biomaterial that can regenerate damaged skeletal muscle.
Allegheny Technologies Incorporated today provided guidance for the third quarter 2010. ATI expects net income per share for the third quarter 2010 before certain charges to be approximately $0.26.
A mouse model of endometriosis has been developed that produces endometriosis lesions similar to those found in humans, according to a report published in The American Journal of Pathology.
Duke University researchers have identified a receptor on the surface of cells that may give them another avenue of attack against glioblastoma, the most common and most deadly type of brain cancer.
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease - pridopidine or dopamine stabiliser ACR16 - might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival.
› Verified 2 days ago
The rate of readmission show you whether patients who were being treated regularly at Fmcna - Faulkner County were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 32.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 49.9 |
| Readmission Rate: Lower Confidence Limit | 17.7 |
News Archive
The National Institutes of Health has awarded a three-year, $437,248 grant to a University of Arkansas biomedical engineering researcher to design and test a biomaterial that can regenerate damaged skeletal muscle.
Allegheny Technologies Incorporated today provided guidance for the third quarter 2010. ATI expects net income per share for the third quarter 2010 before certain charges to be approximately $0.26.
A mouse model of endometriosis has been developed that produces endometriosis lesions similar to those found in humans, according to a report published in The American Journal of Pathology.
Duke University researchers have identified a receptor on the surface of cells that may give them another avenue of attack against glioblastoma, the most common and most deadly type of brain cancer.
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease - pridopidine or dopamine stabiliser ACR16 - might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival.
› Verified 2 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Fmcna - Faulkner County get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.13 (As Expected) |
| SIR: Upper Confidence Limit | 3.74 |
| SIR: Lower Confidence Limit | .19 |
News Archive
The National Institutes of Health has awarded a three-year, $437,248 grant to a University of Arkansas biomedical engineering researcher to design and test a biomaterial that can regenerate damaged skeletal muscle.
Allegheny Technologies Incorporated today provided guidance for the third quarter 2010. ATI expects net income per share for the third quarter 2010 before certain charges to be approximately $0.26.
A mouse model of endometriosis has been developed that produces endometriosis lesions similar to those found in humans, according to a report published in The American Journal of Pathology.
Duke University researchers have identified a receptor on the surface of cells that may give them another avenue of attack against glioblastoma, the most common and most deadly type of brain cancer.
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease - pridopidine or dopamine stabiliser ACR16 - might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival.
› Verified 2 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Fmcna - Faulkner County's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 22 |
| Transfusion Rate in facility | 55.6 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 211.3 |
| Transfusion Rate: Lower Confidence Limit | 17.2 |
News Archive
The National Institutes of Health has awarded a three-year, $437,248 grant to a University of Arkansas biomedical engineering researcher to design and test a biomaterial that can regenerate damaged skeletal muscle.
Allegheny Technologies Incorporated today provided guidance for the third quarter 2010. ATI expects net income per share for the third quarter 2010 before certain charges to be approximately $0.26.
A mouse model of endometriosis has been developed that produces endometriosis lesions similar to those found in humans, according to a report published in The American Journal of Pathology.
Duke University researchers have identified a receptor on the surface of cells that may give them another avenue of attack against glioblastoma, the most common and most deadly type of brain cancer.
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease - pridopidine or dopamine stabiliser ACR16 - might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival.
› Verified 2 days ago
The rate of mortality show you whether patients who were being treated regularly at Fmcna - Faulkner County lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 132 |
| Mortality Rate in facility | 16.8 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 27.4 |
| Mortality Rate: Lower Confidence Limit | 9.6 |
News Archive
The National Institutes of Health has awarded a three-year, $437,248 grant to a University of Arkansas biomedical engineering researcher to design and test a biomaterial that can regenerate damaged skeletal muscle.
Allegheny Technologies Incorporated today provided guidance for the third quarter 2010. ATI expects net income per share for the third quarter 2010 before certain charges to be approximately $0.26.
A mouse model of endometriosis has been developed that produces endometriosis lesions similar to those found in humans, according to a report published in The American Journal of Pathology.
Duke University researchers have identified a receptor on the surface of cells that may give them another avenue of attack against glioblastoma, the most common and most deadly type of brain cancer.
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease - pridopidine or dopamine stabiliser ACR16 - might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival.
› Verified 2 days ago
Davita - Conway Dialysis Ctr Location: 2445 Christina Ln, Conway, Arkansas, 72034 Phone: (501) 328-2186 |
Fmcna - Faulkner County Location: 201 Skyline Dr Ste 32, Conway, Arkansas, 72032 Phone: (501) 329-7715 |
News Archive
The National Institutes of Health has awarded a three-year, $437,248 grant to a University of Arkansas biomedical engineering researcher to design and test a biomaterial that can regenerate damaged skeletal muscle.
Allegheny Technologies Incorporated today provided guidance for the third quarter 2010. ATI expects net income per share for the third quarter 2010 before certain charges to be approximately $0.26.
A mouse model of endometriosis has been developed that produces endometriosis lesions similar to those found in humans, according to a report published in The American Journal of Pathology.
Duke University researchers have identified a receptor on the surface of cells that may give them another avenue of attack against glioblastoma, the most common and most deadly type of brain cancer.
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease - pridopidine or dopamine stabiliser ACR16 - might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival.
› Verified 2 days ago